- Home
- BNC vs KZIA Comparison
BNC vs KZIA Comparison
Compare BNC & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNC
- KZIA
- Stock Information
- Founded
- BNC N/A
- KZIA 1994
- Country
- BNC United States
- KZIA Australia
- Employees
- BNC N/A
- KZIA N/A
- Industry
- BNC Industrial Machinery/Components
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- BNC Industrials
- KZIA Health Care
- Exchange
- BNC Nasdaq
- KZIA Nasdaq
- Market Cap
- BNC 13.7M
- KZIA 11.7M
- IPO Year
- BNC N/A
- KZIA 1999
- Fundamental
- Price
- BNC $27.34
- KZIA $8.17
- Analyst Decision
- BNC
- KZIA Strong Buy
- Analyst Count
- BNC 0
- KZIA 2
- Target Price
- BNC N/A
- KZIA $14.00
- AVG Volume (30 Days)
- BNC 1.0M
- KZIA 75.5K
- Earning Date
- BNC 08-22-2025
- KZIA 08-19-2025
- Dividend Yield
- BNC N/A
- KZIA N/A
- EPS Growth
- BNC N/A
- KZIA N/A
- EPS
- BNC N/A
- KZIA N/A
- Revenue
- BNC $3,478,254.00
- KZIA $1,549,158.00
- Revenue This Year
- BNC N/A
- KZIA N/A
- Revenue Next Year
- BNC N/A
- KZIA $49.25
- P/E Ratio
- BNC N/A
- KZIA N/A
- Revenue Growth
- BNC 10.08
- KZIA 248983.08
- 52 Week Low
- BNC $5.60
- KZIA $2.86
- 52 Week High
- BNC $82.88
- KZIA $39.05
- Technical
- Relative Strength Index (RSI)
- BNC N/A
- KZIA 46.19
- Support Level
- BNC N/A
- KZIA $7.40
- Resistance Level
- BNC N/A
- KZIA $8.99
- Average True Range (ATR)
- BNC 0.00
- KZIA 0.64
- MACD
- BNC 0.00
- KZIA -0.23
- Stochastic Oscillator
- BNC 0.00
- KZIA 25.93
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.